UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Leukemia, 2010-06, Vol.24 (6), p.1121-1127

2010

Volltextzugriff (PDF)

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Leukemia, 2014-07, Vol.28 (7), p.1529-1536

2014

Volltextzugriff (PDF)

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment

Annals of oncology, 2022-01, Vol.33 (1), p.109-111

2022

Volltextzugriff (PDF)

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

The Lancet (British edition), 2000-05, Vol.355 (9218), p.1875-1881

2000

Volltextzugriff (PDF)

Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients

Science (American Association for the Advancement of Science), 1997-06, Vol.276 (5320), p.1851-1854

1997

Volltextzugriff (PDF)

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

Leukemia, 2010-10, Vol.24 (10), p.1700-1712

2010

Volltextzugriff (PDF)

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects

QJM : An International Journal of Medicine, 2011-11, Vol.104 (11), p.957-970

2011

Volltextzugriff (PDF)

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.67

2016

Volltextzugriff (PDF)

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

Leukemia, 2012-07, Vol.26 (7), p.1675-1680

2012

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

Journal of clinical pharmacology, 2002-11, Vol.42 (11), p.1228-1236

2002

Volltextzugriff (PDF)

Transthyretin Amyloid Patients >70 Years of Age Appear as Good Candidates for Heart Transplantation

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S387-S387

2017

Volltextzugriff (PDF)

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Leukemia, 2008-08, Vol.22 (8), p.1479-1484

2008

Volltextzugriff (PDF)

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3771-3779

2001

Volltextzugriff (PDF)

Single Center Experience With Amyloid Patients in the Current Era of Disease Specific Medications

The Journal of heart and lung transplantation, 2015-04, Vol.34 (4), p.S184-S184

2015

Volltextzugriff (PDF)

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma

Blood, 1997-12, Vol.90 (11), p.4278-4282

1997

Volltextzugriff (PDF)

Identification of a New, Unorthodox Member of the MAGE Gene Family

Genomics (San Diego, Calif.), 1999-07, Vol.59 (2), p.161-167

1999

Volltextzugriff (PDF)

A Phase I Dose-ranging Trial of Monthly Infusions of Zoledronic Acid for the Treatment of Osteolytic Bone Metastases

Clinical cancer research, 2001-03, Vol.7 (3), p.478-485

2001

Volltextzugriff (PDF)

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1551-1560

2016

Volltextzugriff (PDF)

HHV-8 Is Present in Multiple Myeloma Patients

Blood, 1999-05, Vol.93 (10), p.3157-3159

1999

Volltextzugriff (PDF)

Effects of arbuscular mycorrhizal fungi formulations on the root morphological traits of rooted cuttings of two fig ( Ficus carica L.) cultivars

Acta horticulturae, 2021-05 (1310), p.61-68

2021

Volltextzugriff (PDF)

1611P Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic

Annals of oncology, 2021-09, Vol.32, p.S1150-S1150

2021

Volltextzugriff (PDF)

Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide

Blood, 1996-09, Vol.88 (5), p.1805-1812

1996

Volltextzugriff (PDF)

The Hematopoietic Stem Cell Antigen, CD34, Is Not Expressed on the Malignant Cells in Multiple Myeloma

Blood, 1994-11, Vol.84 (10), p.3283-3290

1994

Volltextzugriff (PDF)

Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts

Bone marrow transplantation (Basingstoke), 1996-07, Vol.18 (1), p.103-110

1996

Volltextzugriff (PDF)

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Leukemia, 2008-08, Vol.22 (8), p.1649-1649

2008

Volltextzugriff (PDF)

1 – 25 von 227

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201)
Mit Volltextzugriff
(191)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Humans
(110)
Life Sciences & Biomedicine
(106)
Biological And Medical Sciences
(61)
Medical Sciences
(58)
Female
(47)
Hematology
(47)
Male
(44)
Middle Aged
(43)
Oncology
(43)
Aged
(40)
Adult
(37)
Multiple Myeloma
(33)
Multiple Myeloma - Drug Therapy
(23)
Multiple Myeloma - Pathology
(22)
Immunodeficiencies. Immunoglobulinopathies
(19)
Immunoglobulinopathies
(19)
Immunopathology
(19)
Patients
(17)
Hematologic And Hematopoietic Diseases
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

Kaposi's Sarcoma-Associated Herpesvirus Infection of Bone Marrow Dendritic Cells from Multiple Myeloma Patients

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects

A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

Transthyretin Amyloid Patients >70 Years of Age Appear as Good Candidates for Heart Transplantation

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

Single Center Experience With Amyloid Patients in the Current Era of Disease Specific Medications

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma

Identification of a New, Unorthodox Member of the MAGE Gene Family

A Phase I Dose-ranging Trial of Monthly Infusions of Zoledronic Acid for the Treatment of Osteolytic Bone Metastases

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

HHV-8 Is Present in Multiple Myeloma Patients

Effects of arbuscular mycorrhizal fungi formulations on the root morphological traits of rooted cuttings of two fig ( Ficus carica L.) cultivars

1611P Health-related quality of life, vaccine uptake and immune response among cancer patients undergoing treatment during the COVID-19 pandemic

Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide

The Hematopoietic Stem Cell Antigen, CD34, Is Not Expressed on the Malignant Cells in Multiple Myeloma

Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

Suchergebnisse filtern